[Translation] Single-arm, open-label, safety, tolerability, pharmacokinetics and anti-tumor efficacy of HJ197 capsules in patients with advanced hepatocellular carcinoma.
主要目的:评价 HJ197 胶囊多次口服给药治疗晚期肝细胞癌(HCC)患者的安全性及耐受性,确定最大耐受剂量(MTD)及 II 期推荐剂量(RP2D)
[Translation] Main objective: To evaluate the safety and tolerability of multiple oral administration of HJ197 capsules in the treatment of patients with advanced hepatocellular carcinoma (HCC), and to determine the maximum tolerated dose (MTD) and phase II recommended dose (RP2D)